S-3 424B5 EX-FILING FEES 333-276344 0001484565 SOLENO THERAPEUTICS INC The prospectus is not a final prospectus for the related offering. 0001484565 2025-07-10 2025-07-10 0001484565 1 2025-07-10 2025-07-10 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

SOLENO THERAPEUTICS INC

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Common Stock, par value $0.001 per share 457(r) 2,705,882 $ 85.00 $ 229,999,970.00 0.0001531 $ 35,213.00
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 229,999,970.00

$ 35,213.00

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 35,213.00

Offering Note

1

In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), Soleno Therapeutics, Inc. (the "Registrant") initially deferred payment of all of the registration fees for the registration statement on Form S-3ASR (File No. 333-276344), filed on January 2, 2024 (the "Registration Statement"). This "Calculation of Filing Fee Table" shall be deemed to update the "Calculation of Registration Fee" table in the Registration Statement. The prospectus to which this Exhibit is attached is a final prospectus supplement for the related offering. The number of shares registered includes 352,941 shares of common stock that the underwriters have an option to purchase.